Comparing Ibrance vs Tykerb
Ibrance Remove Ibrance from your drug comparison | Tykerb Remove Tykerb from your drug comparison |
---|
Ibrance palbociclib Remove Ibrance from your drug comparison | Tykerb lapatinib Remove Tykerb from your drug comparison | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ibrance is a CDK4/6 inhibitor that may be used to treat advanced or metastatic hormone-receptor-positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) breast cancer in combination... View more |
Prescribed for Breast Cancer - Metastatic, Breast Cancer. Tykerb may also be used for purposes not listed in this medication guide. |
|
|||||||||||||||
Prescription only |
Prescription only |
||||||||||||||||
Ratings & ReviewsRecent helpful reviews |
|||||||||||||||||
6.4
For Breast Cancer, Metastatic: I was diagnosed with Breast Cancer, Metastatic MBC (liver and bones) Feb 2020. I am having my 5th cycle of Ibrance and Letrozol now and I feel great. First two months were hard to manage, I felt very tired, no appetite and lots of bad headaches. During my 3rd cycle I stated to feel suddenly better and now I do not have any side effects at all. The combo works for me, but quite slowly. My markers are getting down, my liver tests are better, but far from normal.But I feel great, like normal me. I will switch to another drug soon. |
10.0
For Breast Cancer, Metastatic: Tykerb along with Xeloda have stabilized my tumors. I have been on these medicines for a year. |
||||||||||||||||
Drug Class |
|||||||||||||||||
Side Effects |
|||||||||||||||||
Common side effects include: decreased neutrophils. See the full Ibrance side effects document. |
See the full Tykerb side effects document. |
||||||||||||||||
Pricing and Coupons* Prices are without insurance |
|||||||||||||||||
View all Ibrance prices |
View all Tykerb prices and generic prices |
||||||||||||||||
Generic Availability |
|||||||||||||||||
No |
|||||||||||||||||
Dosage Form(s) Available |
|||||||||||||||||
|
|
||||||||||||||||
Brand Names |
|||||||||||||||||
N/A |
N/A |
||||||||||||||||
Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. |
|||||||||||||||||
29 hours |
24 hours |
||||||||||||||||
CSA Schedule**View glossary of terms. |
|||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category |
|||||||||||||||||
Summary unavailable. See the full Pregnancy Warnings document. |
Category D
Positive evidence of risk
See the full Pregnancy Warnings document. |
||||||||||||||||
FDA Alerts |
|||||||||||||||||
N/A |
|||||||||||||||||
Drug Interactions |
|||||||||||||||||
A total of 332 drugs are known to interact with Ibrance:
|
A total of 545 drugs are known to interact with Tykerb:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions |
|||||||||||||||||
|
|
||||||||||||||||
Disease Interactions |
|||||||||||||||||
First Approval Date |
|||||||||||||||||
February 03, 2015 |
March 13, 2007 |
||||||||||||||||
WADA ClassView World Anti-Doping Agency classifications. |
|||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information |
|||||||||||||||||
Consumer Resources |
|||||||||||||||||
Professional Resources |
|||||||||||||||||
Related Treatment Guide |
|||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
For Breast Cancer, Metastatic: I began taking Ibrance, Faslodex and Zometa in Febraury 2019. Since then I have had three CT Scans. The CT Scans have shown marked reduction. I have had few side effects if any. This drug was designed to give cancer patients like me more time. I am privately insured. The Pfizer program pays for my out of pocket cost each month.